Cargando…

Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers

BACKGROUND AND AIM: MicroRNAs are small non-coding RNAs that play important regulatory roles in a variety of biological processes, including complex metabolic processes, such as energy and lipid metabolism, which have been studied in the context of diabetes and obesity. Some particular microRNAs hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Pescador, Nuria, Pérez-Barba, Milagros, Ibarra, José María, Corbatón, Arturo, Martínez-Larrad, María Teresa, Serrano-Ríos, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817315/
https://www.ncbi.nlm.nih.gov/pubmed/24204780
http://dx.doi.org/10.1371/journal.pone.0077251
_version_ 1782478053913395200
author Pescador, Nuria
Pérez-Barba, Milagros
Ibarra, José María
Corbatón, Arturo
Martínez-Larrad, María Teresa
Serrano-Ríos, Manuel
author_facet Pescador, Nuria
Pérez-Barba, Milagros
Ibarra, José María
Corbatón, Arturo
Martínez-Larrad, María Teresa
Serrano-Ríos, Manuel
author_sort Pescador, Nuria
collection PubMed
description BACKGROUND AND AIM: MicroRNAs are small non-coding RNAs that play important regulatory roles in a variety of biological processes, including complex metabolic processes, such as energy and lipid metabolism, which have been studied in the context of diabetes and obesity. Some particular microRNAs have recently been demonstrated to abundantly and stably exist in serum and to be potentially disease-specific. The aim of this profiling study was to characterize the expression of miRNA in serum samples of obese, nonobese diabetic and obese diabetic individuals to determine whether miRNA expression was deregulated in these serum samples and to identify whether any observed deregulation was specific to either obesity or diabetes or obesity with diabetes. PATIENTS AND METHODS: Thirteen patients with type 2 diabetes, 20 obese patients, 16 obese patients with type 2 diabetes and 20 healthy controls were selected for this study. MiRNA PCR panels were employed to screen serum levels of 739 miRNAs in pooled samples from these four groups. We compared the levels of circulating miRNAs between serum pools of each group. Individual validation of the twelve microRNAs selected as promising biomarkers was carried out using RT-qPCR. RESULTS: Three serum microRNAs, miR-138, miR-15b and miR-376a, were found to have potential as predictive biomarkers in obesity. Use of miR-138 or miR-376a provides a powerful predictive tool for distinguishing obese patients from normal healthy controls, diabetic patients, and obese diabetic patients. In addition, the combination of miR-503 and miR-138 can distinguish diabetic from obese diabetic patients. CONCLUSION: This study is the first to show a panel of serum miRNAs for obesity, and compare them with miRNAs identified in serum for diabetes and obesity with diabetes. Our results support the use of some miRNAs extracted from serum samples as potential predictive tools for obesity and type 2 diabetes.
format Online
Article
Text
id pubmed-3817315
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38173152013-11-07 Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers Pescador, Nuria Pérez-Barba, Milagros Ibarra, José María Corbatón, Arturo Martínez-Larrad, María Teresa Serrano-Ríos, Manuel PLoS One Research Article BACKGROUND AND AIM: MicroRNAs are small non-coding RNAs that play important regulatory roles in a variety of biological processes, including complex metabolic processes, such as energy and lipid metabolism, which have been studied in the context of diabetes and obesity. Some particular microRNAs have recently been demonstrated to abundantly and stably exist in serum and to be potentially disease-specific. The aim of this profiling study was to characterize the expression of miRNA in serum samples of obese, nonobese diabetic and obese diabetic individuals to determine whether miRNA expression was deregulated in these serum samples and to identify whether any observed deregulation was specific to either obesity or diabetes or obesity with diabetes. PATIENTS AND METHODS: Thirteen patients with type 2 diabetes, 20 obese patients, 16 obese patients with type 2 diabetes and 20 healthy controls were selected for this study. MiRNA PCR panels were employed to screen serum levels of 739 miRNAs in pooled samples from these four groups. We compared the levels of circulating miRNAs between serum pools of each group. Individual validation of the twelve microRNAs selected as promising biomarkers was carried out using RT-qPCR. RESULTS: Three serum microRNAs, miR-138, miR-15b and miR-376a, were found to have potential as predictive biomarkers in obesity. Use of miR-138 or miR-376a provides a powerful predictive tool for distinguishing obese patients from normal healthy controls, diabetic patients, and obese diabetic patients. In addition, the combination of miR-503 and miR-138 can distinguish diabetic from obese diabetic patients. CONCLUSION: This study is the first to show a panel of serum miRNAs for obesity, and compare them with miRNAs identified in serum for diabetes and obesity with diabetes. Our results support the use of some miRNAs extracted from serum samples as potential predictive tools for obesity and type 2 diabetes. Public Library of Science 2013-10-15 /pmc/articles/PMC3817315/ /pubmed/24204780 http://dx.doi.org/10.1371/journal.pone.0077251 Text en © 2013 Pescador et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Pescador, Nuria
Pérez-Barba, Milagros
Ibarra, José María
Corbatón, Arturo
Martínez-Larrad, María Teresa
Serrano-Ríos, Manuel
Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers
title Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers
title_full Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers
title_fullStr Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers
title_full_unstemmed Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers
title_short Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers
title_sort serum circulating microrna profiling for identification of potential type 2 diabetes and obesity biomarkers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817315/
https://www.ncbi.nlm.nih.gov/pubmed/24204780
http://dx.doi.org/10.1371/journal.pone.0077251
work_keys_str_mv AT pescadornuria serumcirculatingmicrornaprofilingforidentificationofpotentialtype2diabetesandobesitybiomarkers
AT perezbarbamilagros serumcirculatingmicrornaprofilingforidentificationofpotentialtype2diabetesandobesitybiomarkers
AT ibarrajosemaria serumcirculatingmicrornaprofilingforidentificationofpotentialtype2diabetesandobesitybiomarkers
AT corbatonarturo serumcirculatingmicrornaprofilingforidentificationofpotentialtype2diabetesandobesitybiomarkers
AT martinezlarradmariateresa serumcirculatingmicrornaprofilingforidentificationofpotentialtype2diabetesandobesitybiomarkers
AT serranoriosmanuel serumcirculatingmicrornaprofilingforidentificationofpotentialtype2diabetesandobesitybiomarkers